GUANGZHOU, China, Feb. 23, 2022 (GLOBE NEWSWIRE) -- EHang Holdings Limited (Nasdaq: EH) (“EHang” or the “Company”), the world's leading autonomous aerial vehicle (“AAV”) technology platform company, ...
The end goal is to develop AAV vectors that target specific pancreatic cell types and contain payloads that express therapeutic genes under control of cell-specific regulatory elements. This new ...
Necrotizing and crescentic glomerulonephritis arises in all 3 AAV subtypes: GPA, MPA, and EGPA. According to findings from a study recently published in the journal Kidney International, among ...
The great hope for gene therapy is that one day it will be out of the clinic and into mainstream therapeutics. Bearing enormous potential to treat or cure disease, such technology can replace a ...
The "Adeno-Associated Viral (AAV) Vector Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Therapy, Therapeutic Area, Route of Administration, Scale of Operation and ...
Glutaric aciduria type I (GA-I) is an inherited disease caused by a mutation of the glutaryl-CoA dehydrogenase (GCDH) gene. The global incidence of GA-I is estimated to be 1/100,000, with around ...
Liver glycogen storage disease type IX (GSD IX) accounts for 25% for all GSD cases, with a prevalence of 1 out of 100,000 patients. GSD IX is caused by deficiency in phosphorylase kinase (PhK), which ...
- Study has now enrolled a total of nine patients across low-dose and high-dose cohorts- On track to report 12-month topline safety, biomarker, and efficacy data from Type II low-dose AXO-AAV-GM1 ...
In patients with ANCA-associated vasculitis (AAV), double seropositivity for MPO-ANCA and PR3-ANCA is linked to worse remission rates compared with either AAV type alone. Idiopathic ANCA-associated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback